Study offers clue as to why alcohol is addicting: Drinking releases brain endorphins

(Medical Xpress) -- Drinking alcohol leads to the release of endorphins in areas of the brain that produce feelings of pleasure and reward, according to a study led by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

The finding marks the first time that endorphin release in the and orbitofrontal cortex in response to has been directly observed in humans.

Endorphins are small proteins with opiate-like effects that are produced naturally in the brain.

This video is not supported by your browser at this time.

Video: The nucleus accumbens, hand drawn in red on the MRI brain scan (left) of a control subject, produces feelings of pleasure. When carfentanil, an opiate-like drug, was given, it bound to opioid receptors in the region, as seen in red on the PET scan (right). When subjects drank alcohol, naturally occurring opioids, or endorphins, were released and bound to the same receptors, preventing cartenefil from binding. Science/AAAS

"This is something that we've speculated about for 30 years, based on animal studies, but haven't observed in humans until now," said lead author Jennifer Mitchell, PhD, clinical project director at the Gallo Center and an adjunct assistant professor of neurology at UCSF. "It provides the first direct evidence of how makes people feel good."

The discovery of the precise locations in the brain where endorphins are released provides a possible target for the development of more effective drugs for the treatment of alcohol abuse, said senior author Howard L. Fields, MD, PhD, a professor of neurology and Endowed Chair in Pharmacology of Addiction in Neurology at UCSF and director of human clinical research at the Gallo Center.

The study appears on January 11, 2012, in Science Translational Medicine.

The researchers used positron , or PET imaging, to observe the immediate in the brains of 13 heavy drinkers and 12 matched "control" subjects who were not heavy drinkers.

In all of the subjects, led to a release of endorphins. And, in all of the subjects, the more endorphins released in the nucleus accumbens, the greater the feelings of pleasure reported by each drinker.

In addition, the more endorphins released in the , the greater the feelings of intoxication in the , but not in the control subjects.

"This indicates that the brains of heavy or problem drinkers are changed in a way that makes them more likely to find alcohol pleasant, and may be a clue to how problem drinking develops in the first place," said Mitchell. "That greater feeling of reward might cause them to drink too much."

Before drinking, the subjects were given injections of radioactively tagged carfentanil, an opiate-like drug that selectively binds to sites in the brain called opioid receptors, where endorphins also bind. As the radioactive carfentanil was bound and emitted radiation, the receptor sites "lit up" on PET imaging, allowing the researchers to map their exact locations.

The subjects were then each given a drink of alcohol, followed by a second injection of radioactive carfentanil, and scanned again with . As the natural endorphins released by drinking were bound to the opioid receptor sites, they prevented the carfentanil from being bound. By comparing areas of radioactivity in the first and second PET images, the researchers were able to map the exact locations — areas of lower radioactivity — where endorphins were released in response to drinking.

The researchers found that endorphins released in response to drinking bind to a specific type of opioid receptor, the Mu receptor.

This result suggests a possible approach to improving the efficacy of treatment for alcohol abuse through the design of better medications than naltrexone, said Fields, who collaborated with Mitchell in the design and analysis of the study.

Fields explained that naltrexone, which prevents binding at opioid receptor sites, is not widely accepted as a treatment for alcohol dependence — "not because it isn't effective at reducing drinking, but because some people stop taking it because they don't like the way it makes them feel," he said.

"Naltrexone blocks more than one opioid receptor, and we need to know which blocking action reduces drinking and which causes the unwanted side effects," he said. "If we better understand how control drinking, we will have a better chance of creating more targeted therapies for substance addiction. This paper is a significant step in that direction because it specifically implicates the Mu in alcohol reward in humans."

Related Stories

Alcohol abuse is in the genes

Jun 29, 2007

According to a study by the research group "Alcoholism and drug addiction", of the University of Granada (Universidad de Granada), although there are no specific reasons to become an alcoholic, many social, family, environmental, ...

Receptor variant influences dopamine response to alcohol

May 18, 2010

A genetic variant of a receptor in the brain's reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers ...

Naltrexone can help heavy social drinkers quit smoking

Mar 19, 2009

Naltrexone, an opioid antagonist approved in 1994 by the U.S. Food and Drug Administration for alcohol-dependence (AD) treatment, can reduce relapse rates among AD patients. Research on naltrexone's effectiveness on nicotine ...

Recommended for you

Know the brain, and its axons, by the clothes they wear

13 hours ago

(Medical Xpress)—It is widely know that the grey matter of the brain is grey because it is dense with cell bodies and capillaries. The white matter is almost entirely composed of lipid-based myelin, but ...

Turning off depression in the brain

Apr 17, 2014

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Rapid whole-brain imaging with single cell resolution

Apr 17, 2014

A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to ...

User comments